• Sensex   38506.09   291.62  sensex_up_arr
  • Nifty   11428.30   87.15   sensex_up_arr
  • Bank Nifty   28555.10   1.32   sensex_up_arr
  • BSE Midcap   13940.15   0.72  sensex_up_arr
  • USDINR   71.64   0.49   sensex_up_arr
logo
PRAVIN RATILAL SHARE
AND STOCK BROKERS LTD
Member :    NSE   |   BSE   |   DP : NSDL
Director's Report
Home >> Markets >> Corporate Information >> Director's Report
Zota Health Care LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:538426
ISIN Demat:INE358U01012
Book Value(Rs):28.06
NSE Symbol:ZOTA
Div & Yield %:0.52
Market Cap (Rs Cr.):469.97
P/E(TTM):84.67
EPS(TTM):2.26
Face Value(Rs):10
  Change Company 

Your directors are please to present their Annual Report along with the Audited statement of Accounts for the year ended on 31st March, 2017.

FINANCIAL RESULTS (Rs. in Lakhs)
Particulars

For the year ended 31-03-2017

For the year ended 31-03-2016

Revenue from operations 7158.00 6473.33
Other Income 5.64 7.69
Profit before tax and Exceptional Items 836.17 772.42
Exceptional Items 0 0
Profit before Taxation 836.17 772.42
Income Tax 285.96 269.25
Deferred Tax -4.52 -7.76
Profit after Taxation 554.11 510.93
Less: Proposed Dividend 350.87 143.63
Less: Tax on Dividend 71.43 29.24

DIVIDEND

The Board is pleased to recommend a dividend of 20% i.e. Re.2 per equity share for the financial year 2016-17.The dividend if approved by the members will be paid to the members within time limit defined in the Companies Act, 2013.

TRANSFER TO RESERVE

The company does not propose to transfer any amount to General Reserves.

STATEMENT OF COMPANY'S AFFAIRS

During the year, Revenue of the Company increased by 10.58% i.e. from Rs. 6473.33 lakhs to Rs. 7158.00 lakhs. Profit before tax increase 8.25% i.e. from Rs. 772.42 lakhs to Rs. 836.17 lakhs Profit after tax increase by 8.45% i.e. from Rs. 510.93 lakhs to Rs. 554.11 lakhs.

MATERIAL CHANGES

The company had came out with a public issue of 46,80,000 equity shares comprising of offer for sale of 15,00,000 equity shares by promoters and fresh issue of 31,80,000 equity shares for Rs. 125 each including a share premium of Rs. 115 per equity share. The IPO was a huge success and the resulting shares have been listed on the NSE emerge platform of NSE, Mumbai. Other than this there are no Material change occurred between the end of the financial year of the company to which the financial statements related and the date of the report, which is affecting the financial position of the company.

STATUTORY AUDITORS

Existing Auditors of our company M/s Pradeep K. Singhi & Associates have completed their tenure of auditor as provided U/s 139(2) of The Companies Act, 2013. So, your board proposes to appoint new statutory auditors.

The Board proposes for the appointment of M/s D S M & CO, Chartered Accountants, having firm registration no. 132003W as a Statutory Auditors of the Company for the period of five years starting from the conclusion of 17th Annual General Meeting till the conclusion of 22nd Annual General meeting subject to ratification at every Annual

General Meeting at such remuneration as may be decided by the Board from time to time. The Company has received letter from the auditors, that their appointment, if made, would be within the prescribed limits under section 139(2) of the Companies Act, 2013 and that they are not disqualified for such appointment under section 141 of the Companies Act, 2013. Your Board proposes the ratification of appointment of auditors.

EXTRACT OF ANNUAL RETURN

The Extract of Annual Return as required under section 92(3) of the Companies Act, 2013 and Rule 12 (1) of the Companies (Management and Administration) Rules, 2014 in Form MGT-9 is annexed herewith for your kind perusal and information. (Annexure - 1)

COMMENTS ON AUDITOR'S REPORT

The notes referred to in the Auditor Report are self-explanatory and they do not call for any further explanation as required under section 134 of the Companies Act, 2013.

DETAILS OF DIRECTORS AND KEY MANAGERIAL PERSONNEL

The Board of Directors comprises of eight directors out of which one is Non-Executive Chairman, one is Executive Managing Director, three are Executive Whole Time Directors and remaining three are Non-Executive Independent Directors. As on date of this report Board of Directors of the company is as follows:

Name of Directors Category & Designation
Mr. Ketankumar Chandulal Zota Non-Executive Chairman
Mr. Moxesh ketanbhai Zota Executive Managing Director
Mr. Himanshu Muktilal Zota Executive Whole Time Director
Mr. Manukant Chandulal Zota Executive Whole Time Director
Mr. Kamlesh Rajnikant Zota Executive Whole Time Director
Mr. Saileshkumar Sevantilal Shah Non-Executive Independent Director
Mrs. Varsaben Gaurang Mehta Non-Executive Additional Independent Director
Mr. Mahesh Mavjibhai Prajapati Non-Executive Independent Director

During the year, Mr. Gaurang Rashmikant Mehta was resigned from the post of independent director w.e.f. 10th September, 2016. During the year, Company has appointed Mr. Moxesh Ketanbhai Zota as the Managing Director w.e.f. 07th October, 2016 and Mrs. Varsaben Gaurang Mehta as an additional independent director w.e.f. 10th September, 2016.

Pursuant to Sections 149, 152 and other applicable provisions of the Companies Act, 2013, one-third of the directors are liable to retire by rotation, and if eligible offer themselves for re-appointment. In this Annual General Meeting Mr. Himanshu Muktilal Zota, Whole-time Director of the Company is liable to retire by rotation and being eligible to offer himself for re-appointment.

The Key Managerial Personnel (KMP) in the Company as per Section 2(51) and 203 of the Companies Act, 2013 are as follows:

Name of Directors Category & Designation
Mr. Moxesh ketanbhai Zota Executive Managing Director
Mr. Himanshu Muktilal Zota Executive Whole Time Director
Mr. Manukant Chandulal Zota Executive Whole Time Director
Mr. Kamlesh Rajnikant Zota Executive Whole Time Director
Mr. Viral Mandviwala Chief Financial Officer
Mr. Ashvin Variya Company Secretary

MEETING OF THE BOARD OF DIRECTORS:

During the year, there were nine Board meetings held. Details of the same are as follows:

Sr. No. Date of Meeting

Board Strength

No. of Director Present

1 02/04/2016 7 7
2 15/04/2016 7 7
3 25/07/2016 7 7
4 10/09/2016 8 8
5 07/10/2016 7 6
6 22/10/2016 8 7
7 05/11/2016 8 7
8 25/01/2017 8 8
9 04/03/2017 8 8

Deposits

During the year, Company has not accepted any deposits from public within the meaning of the Section 73 of the Companies Act, 2013.

RELATED PARTY TRANSACTION

With reference to Section 134(3)(h) of the Companies Act, 2013, all contracts and arrangements with related parties under section 188 of the Companies Act, 2013 entered by the Company during the financial year, were in ordinary course of business and at arm's length basis. Details of the related party transactions made during the year are attached as Annexure-2 in form AOC-2 for your kind perusal and information.

LOANS, GUARANTEES AND INVESTMENT

With reference to Section 134(3)(g) of the Companies Act, 2013, loans, guarantees and investments made under section 186 of the Companies Act, 2013 are as under:

Sr. No. Date of transaction Name of the Company Purpose of Transaction

Amount involved in Transaction

1 Earlier year Prime Co-op .Bank Investment in equity shares 100

CORPORATE SOCIAL RESPONSIBILITY

On recommendation of Corporate Social Responsibility Committee Board has formulated Corporate Social Responsibility Policy and adopted the same. The detailed CSR policy of the Company is available on the website of the Company www.zotahealthcare.com. Details of CSR activities carried out by the Company are as per Annexure - 3. Corporate Social Responsibility Committee constituted by the Company has met two times during the last year. A detail of the meeting of CSR committee is as follows:

Sr. No. Date of Meeting

Strength of Committee

No. of Members Present

1 23/07/2016 3 3
2 30/03/2017 3 3

DECLARATION BY INDEPENDENT DIRECTORS

Company has received declaration from all the independent directors duly signed by them stating that they meet the criteria of independence as provided in section 149(6) of the Companies Act, 2013.

NOMINATION AND REMUNERATION COMMITTEE

Company has formulated nomination and remuneration committee comprising three non-executive directors Composition of the Committee is as follows:

Mrs. Varsaben Gaurang Mehta - Chairman & Member
Mr. Mahesh Mavjibhai Prajapati - Member
Mr. Saileshkumar Sevantilal Shah - Member

During the year, three meetings of the nomination and remuneration committee were held. Details of the Meetings are as follows:

Sr. No. Date of Meeting

Strength of Committee

No. of Members Present

1 23/07/2016 3 3
2 10/09/2016 3 3
3 29/09/2016 3 2

(i) Term of Reference of the Committee

To identify persons who are qualified to become Directors and who may be appointed in senior management in accordance with the criteria laid down, recommend to the Board their appointment and removal and shall carry out evaluation of every Director's performance.

To formulate the criteria for determining qualifications, positive attributes and independence of a Director and recommend to the Board a policy, relating to the remuneration for the Directors, Key Managerial Personnel and other employees. The Nomination and Remuneration Committee shall, while formulating the policy ensure that:

(i) the level and composition of remuneration is reasonable and sufficient to attract, retain and motivate Directors of the quality required to run the Company successfully;

(ii) relationship of remuneration to performance is clear and meets appropriate performance benchmarks; and

(iii) remuneration to Directors, Key Managerial Personnel and senior management involves a balance between fixed and incentive pay reflecting short and long-term performance objectives appropriate to the working of the company and its goals: Regularly review the Human Resource function of the Company. Discharge such other function(s) or exercise such power(s) as may be delegated to the Committee by the Board from time to time. Make reports to the Board as appropriate. Review and reassess the adequacy of this charter periodically and recommend any proposed changes to the Board for approval from time to time. Any other work and policy, related and incidental to the objectives of the committee as per provisions of the Act and rules made there under.

(ii) Remuneration Policy:

(a) Remuneration to Executive Directors:

The remuneration paid to executive directors of the Company is recommended by the Nomination and Remuneration Committee of the Company and then Board of the Company approve in their duly held meeting. The remuneration of executive directors are decided by considering various criteria like qualification, experience, responsibilities, value addition to the Company and financial position of the Company. Board is taking permission of the members if required at any time for paying remuneration to executive directors.

(b) Remuneration to Non-Executive Directors:

Company is not paying any remuneration to non-executive and independent directors of the Company.

AUDIT COMMITTEE:

Pursuant to requirement of Section 177(1) of the Companies Act, 2013 Company has formulated Audit Committee. Composition of the Audit Committee is as follows:

Mr. Saileshkumar Sevantilal Shah - Chairman & Member
Mrs. Varsaben Gaurang Mehta - Member
Mr. Himanshu Muktilal Zota - Member

During the year, Audit Committee has met four times details of the same are as follows:

Sr. No. Date of Meeting

Strength of Committee

No. of Members Present

1 28/06/2016 3 3
2 21/07/2016 3 3
3 14/10/2016 3 2
4 24/02/2017 3 3

The term of references of audit committee are to recommend for appointment of statutory auditor, approve related party transactions, examination of financial statements and auditor's report, scrutinize inter corporate loans and investments, evaluation of internal financial control and risk management, review and monitor auditors independence and performance and effectiveness of audit process.

STAKEHOLDERS, SHAREHOLDERS AND INVESTOR GRIEVANCES COMMITTEE

To solve the investors grievances Company has formulated Stakeholder's, Shareholders and Investor Grievance Committee. Composition of the Committee is as follows:

Mr. Mahesh Mavjibhai Prajapati - Chairman & Member
Mr. Himanshu Muktilal Zota - Member
Mr. Manukant Chandulal Zota - Member

During the year, Stakeholder's, Shareholders and Investor Grievance Committee has met four times details of the meetings are as follows:

Sr. No. Date of Meeting

Strength of Committee

No. of Members Present

1 21/06/2016 3 3
2 29/09/2016 3 3
3 23/12/2016 3 3
4 24/03/2017 3 3

VIGIL MECHANISM

The Company has established a Vigil Mechanism to deal with instances of fraud and mismanagement, if any. The policy has a systematic mechanism for directors and employees to report concerns about unethical behavior, actual or suspected fraud or violation of the Company's Code of Conduct or policy.

RISK MANAGEMENT

Risks are events, situations or circumstances which may lead to negative consequences on the Company's business. Risk Management is a structured approach to manage uncertainty. An enterprise wide approach to Risk Management is being adopted by the Company and key risks will now be managed within a unitary framework. As a formal roll-out, all business divisions and corporate functions will embrace Risk Management Policy and Guidelines, and make use of these in their decision making. Key business risks and their mitigation are considered in the annual/strategic business plans and in periodic management reviews. The risk management process over the period of time will become embedded into the Company's business system and processes, such that our responses to risk remain current and dynamic.

DIRECTORS RESPONSIBILITY STATEMENT

Pursuant to the provisions of Section 134(5) of the Companies Act, 2013, your directors hereby confirm:

A. That in preparation of the annual accounts, the applicable accounting standards have been followed along with proper explanation relating to material departments;

B. That the directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs if the Company at the end of the financial year and of the profit and loss of the Company for that period;

C. That the directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company for preventing and detecting fraud and other irregulations;

D. That the directors had prepared the annual accounts on a going concern basis;

E. The directors had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively;

F. The directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

BOARD EVALUATION

The performance of the board was evaluated by the board after seeking inputs from all the directors on the basis of the criteria such as the board composition and structure, effectiveness of board processes, information and functioning, etc. The performance of the committees was evaluated by the board after seeking inputs from the committee members on the basis of the criteria such as the composition of committees, effectiveness of committee meetings, etc.

The board and the nomination and remuneration committee reviewed the performance of the individual directors on the basis of the criteria such as the contribution of the individual director to the board and committee meetings like preparedness on the issues to be discussed, meaningful and constructive contribution and inputs in meetings, etc. In addition, the chairman was also evaluated on the key aspects of his role.

In a separate meeting of independent directors, performance of non-independent directors, performance of the board as a whole and performance of the chairman was evaluated, taking into account the views of executive directors and non-executive directors. Performance evaluation of independent directors was done by the entire board, excluding the independent director being evaluated.

INTERNAL FINANCIAL CONTROL SYSTEM

The Company has a well placed, proper and adequate internal financial control system which ensures that all the assets are safeguarded and protected and that the transactions are authorized recorded and reported correctly. The internal audit covers a wide variety of operational matters and ensures compliance with specific standard with regards to availability and suitability of policies and procedures. During the year no reportable material weakness in the design or operation were observed.

CORPORATE GOVERNANCE:

Your Company has incorporated the appropriate standards for corporate governance. Pursuant to Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company is not required to mandatorily comply with the provisions of certain regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Hence, company is not filing Corporate Governance Report to stock exchange quarterly. However, as per Regulation 34(3) real with Schedule V of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015 company is giving report on corporate governance report in annual report of the company. Corporate Governance Report is as per Annexure - 4.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNING

With reference to Section 134(3) (m) of the Companies Act, 2013, the details of conservation of energy, technology absorption and foreign exchange earnings are as per Annexure - 5.

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

As per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements), Regulation 2015, the Management Discussion and Analysis Report is given in Annexure - 6.

SECRETERIAL AUDITOR

Your board has appointed PCS Ranjit Kejriwal, as secretarial Auditor of the company for the period of 5 consecutive years starting from financial year 2016-17. The secretarial report for the financial year 2016-17 is attached as Annexure - 7.

PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES

There was no employee drawing remuneration in excess of limits prescribed under section 197(12) of the Companies Act, 2013 read with Rule 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. The Disclosure pertaining to remuneration as required under section 197(12) of the Companies Act, 2013 read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Amendment Rules, 2016 are as per Annexure - 8.

SHARE CAPITAL

During the year, Company has not issued any shares with different rights, sweat equity shares or employee stock options.

SUBSIDIARIES, JOINT VENTURE AND ASSOCIATE COMPANIES

The Company does not have any Subsidiary, Holding, Joint Venture or Associate Company.

SEXUAL HARASSMENT OF WOMEN

During the year, there were no cases filed pursuant to the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressed) Act, 2013.

ACKNOWLEDGEMENT:

We would like to thank our Bankers, Auditors, RTA and members for extending their full Co-operation during the year.

For the Board of Director
ZOTA HEALTH CARE LIMITED
Sd/- Sd/-
Ketankumar Chandulal Zota Himanshu Muktilal Zota
Place: Surat Chairman Whole-time Director
Date: 12.07.2017 DIN:00822594 DIN:01097722

Form No. AOC-2

(Pursuant to clause (h) of sub-section (3) of section 134 of the Act and Rule 8(2) of the Companies (Accounts) Rules, 2014) Form for disclosure of particulars of contracts/ arrangements entered into by the company with related parties referred to in sub-section (1) of section 188 of the Companies Act, 2013 including certain arms length transactions under third proviso thereto

1. Details of contracts or arrangements or transactions not at arm's length basis

Name(s) of the related party and nature of relationship Nature of contracts /arrange ments/tr ansactio ns Duration of the contracts / arrange ments/tr ansactio ns Salient terms of the contracts or arrangement s or transactions including the value, if any Justificat ion for entering into such contracts or arrange ments or transacti ons Date(s) of approv al by the Board Amount paid as advance, if any Date on which the special resolution was passed in general meeting as required under first proviso to section 188
NIL

2. Details of material contracts or arrangement or transactions at arm's length basis (Rs.IN LAKHS)

Name(s) of the related party and nature of relationship Nature of contracts/ arrangements/ transactions Duratio n of the contrac ts/ arrange ments / transact ions Salient term of the contracts or arrangements or transactions including the value, if any Date(s) if approval by the Board, if any Amoun t paid as advanc es, if any
1 Himanshu M. Zota Interest N.A. 12% interest on unsecured loan N.A.
2 Himanshu M. Zota [HUF] Interest N.A. 12% interest on unsecured loan N.A.
3 Induben M. Zota Interest N.A. 12% interest on unsecured loan N.A.
4 Kamlesh R. Zota Interest N.A. 12% interest on unsecured loan N.A.
5 Kamlesh R. Zota [HUF] Interest N.A. 12% interest on unsecured loan N.A.
6 Ketan C. Zota [HUF] Interest N.A. 12% interest on unsecured loan N.A.
7 Manisha K. Zota Interest N.A. 12% interest on unsecured loan N.A.
3
8 Manukant C. Zota Interest N.A. 12% interest on unsecured loan
9 Nimisha N. Zota Interest N.A. 12% interest on unsecured loan N.A.
10 Varsha H. Zota Interest N.A. 12% interest on unsecured loan N.A.
11 Jatin A. Zota Salary N.A. 0.45 lakhs per month 26.06.2014
12 Ashokkumar C. Zota Salary N.A. 0.50 lakhs per month 26.06.2014
13 Niral M.Zota Salary N.A. 0.45 lakhs per month 26.06.2014
14 Viren M. Zota Salary N.A. 0.45 lakhs per month 26.06.2014
15 Jatin A. Zota Commission N.A. Commission on sales 26.06.2014
16 Niral M.Zota Commission N.A. Commission on sales 26.06.2014
17 Viren M. Zota Commission N.A. Commission on sales 26.06.2014
18 Himanshu M. Zota Remuneration N.A. 0.75 lakhs per month 26.06.2014
19 Kamlesh R. Zota Remuneration N.A. 0.75 lakhs per month 26.06.2014
20 Ketan C. Zota Remuneration N.A. 0.75 lakhs per month 26.06.2014
21 Manukant C. Zota Remuneration N.A. 0.75 lakhs per month 26.06.2014
22 Moxesh K. Zota Remuneration N.A. 0.75 lakhs per month 07.10.2016
23 Viral A. Mandviwala Salary N.A. N.A. 30.09.2014

AS PER RULE 8 OF COMPANIES (ACCOUNTS) RULES, 2014

A. CONSERVATION OF ENERGY

(i) The steps taken or impact on conservation of energy

(ii) The steps taken by the Company for utilising alternate sources of energy NIL

(iii) The capital investment on energy conservation equipment

B. TECHNOLOGY ABSORPTION

(i) The efforts made towards technology absorption

(ii) The benefits derived like product improvement, cost reduction, product development or import substitution

(iii) In case of imported technology (imported during last three years reckoned from the beginning of the financial year) NIL

a. The details of technology imported b. The year of import

c. Weather the technology been fully absorbed

d. If not fully absorbed areas where absorption has not taken place & reasons thereof

(iv) The expenditure incurred on research & development during the year 2016-17 was Rs. 06 lakhs

C. FOREIGN EXCHANGE EARNING AND OUTGO

The Foreign Exchange earning in terms of actual inflows

Export of goods calculated on FOB basis Export by SEZ unit during the financial year 2016-17 was Rs. 212.55 lakhs

The Foreign Exchange outgo during the year in terms of actual outflows

Foreign Exchange outgo during the financial year 2016-17 was Rs. 25.98 lakhs

ANNEXURE 8

The Disclosures pertaining to remuneration as required under section 197(12) of the companies act' 2013 read with rules 5 (1) of the companies (appointment and remuneration of managerial personnel) Amendment rules, 2016 are as under:

The percentage increase in remuneration of each Director, Chief Financial Officer and Company Secretary during the financial year 2016-17, ratio of the remuneration of the employees of the Company for the financial year 2016-17 and the comparison of remuneration of each Key Managerial Personnel (KMP) against the performance of the Company are as under:

Sr. No. Name of Director/KMP and Designation

Remuneration of Director/KMP for F.Y. 2016-17 (in Rs. lakhs)

% increase in Remuneration in the F.Y. 2016-17

Ratio of Remuneration of each Director/to median remuneration of employees

1 Ketankumar Chandulal Zota* 4.5 NIL 7.16:1
Non-Executive Chairman
2 Moxesh Ketanbhai Zota# 4.5 NIL 7.16:1
Managing Director
3 Himanshu Muktilal Zota 9 NIL 7.16:1
Whole Time Director
4 Kamlesh Rajnikant Zota 9 NIL 7.16:1
Whole Time Director
5 Manukant Chandulal Zota 9 NIL 7.16:1
Whole Time Director
6 Saileshkumar Sevantilal Shah NIL NIL NIL
Non-Executive Independent Director
7 Varsaben Gaurang Mehta NIL NIL NIL
Non-Executive Independent Director
8 Mahesh Mavjibhai Prajapati NIL NIL NIL
Non-Executive Independent Director
9 Viral Madviwala 4.80 11.89 N.A.
Chief Financial Officer
10 Ashvin Variya 3.74 53.91 N.A.
Company Secretary & Compliance Officer

* Mr. Ketankumar Chandulal Zota has received remuneration of Rs. 4.5 lakhs during the year 2016-17 as the Managing Director of the Company and he has resigned from the post of the managing director on 07th October, 2017. Now, he is non-executive chairman of the company.

# Mr. Moxesh Ketanbhai Zota has been appointed as the Managing Director of the company by the Board of Directors of the company on 07th October, 2017.

(i) The median remuneration of employees of the Company during the Financial Year was Rs. 125667/-

(ii) In the Financial year, the median remuneration of employees is increased by 2.19%.

(iii) There were 267 permanent employees on the rolls of the Company as on March 31, 2016;

(iv) Average percentage increase made in the salaries of employees other than the managerial personnel in comparison of the last financial year is 2.19%. There is an average decrease of 46.09% in the remuneration of Key Managerial personnel in comparison to the last financial year.

(v) The remuneration of KMP is as per the recommendations of the Nomination & Remuneration Committee.

(vi) It is hereby affirmed that the remuneration paid is as per the remuneration policy for Directors, Key Managerial Personnel and other Employees.

   

Adani Ports & Special Economic Zone Ltd     413.75   Up   6.30 (1.55%)   Asian Paints Ltd     1,803.10   Up   4.40 (0.24%)   Axis Bank Ltd     690.05   Up   6.55 (0.96%)   Bajaj Auto Ltd     3,011.95   Up   53.90 (1.82%)   Bajaj Finance Ltd     3,879.45   Down   -3.85 (-0.10%)   Bajaj Finserv Ltd     8,035.85   Down   -46.40 (-0.57%)   Bharat Petroleum Corporation Ltd     490.30   Up   4.35 (0.90%)   Bharti Airtel Ltd     383.65   Down   -9.90 (-2.52%)   Bharti Infratel Ltd     256.95   Down   -2.50 (-0.96%)   Britannia Industries Ltd     3,181.10   Up   71.45 (2.30%)   Cipla Ltd     446.55   Up   5.65 (1.28%)   Coal India Ltd     191.15   Up   1.05 (0.55%)   Dr Reddys Laboratories Ltd     2,684.65   Up   32.75 (1.23%)   Eicher Motors Ltd     19,199.10   Up   871.15 (4.75%)   GAIL (India) Ltd     128.10   Up   2.25 (1.79%)   Grasim Industries Ltd     703.70   Up   5.05 (0.72%)   HCL Technologies Ltd     1,084.50   Down   -2.30 (-0.21%)   HDFC Bank Ltd     1,223.05   Up   18.65 (1.55%)   Hero Honda Motors Ltd     2,675.70   Up   66.50 (2.55%)   Hindalco Industries Ltd     192.55   Up   3.85 (2.04%)   Hindustan Unilever Ltd     2,064.40   Up   50.15 (2.49%)   Housing Development Finance Corporation Ltd     2,013.30   Down   -1.45 (-0.07%)   ICICI Bank Ltd     431.85   Up   3.00 (0.70%)   Indian Oil Corporation Ltd     146.45   Up   1.70 (1.17%)   IndusInd Bank Ltd     1,272.25   Up   21.65 (1.73%)   Infosys Technologies Ltd     768.30   Down   -17.80 (-2.26%)   ITC Ltd     247.60   Up   3.50 (1.43%)   JSW Steel Ltd     219.65   Down   -1.80 (-0.81%)   Kotak Mahindra Bank Ltd     1,615.60   Up   30.10 (1.90%)   Larsen & Toubro Ltd     1,432.25   Up   8.30 (0.58%)   Mahindra & Mahindra Ltd     583.40   Up   14.75 (2.59%)   Maruti Suzuki India Ltd     6,985.75   Up   164.65 (2.41%)   Nestle India Ltd     14,086.80   Down   -82.20 (-0.58%)   NIFTY (S&P CNX)     11,428.30   Up   87.15 (0.77%)   NTPC Ltd     119.40   Up   1.65 (1.40%)   Oil & Natural Gas Corpn Ltd     138.65   Up   3.40 (2.51%)   Power Grid Corporation of India Ltd     201.25   Up   2.85 (1.44%)   Reliance Industries Ltd     1,364.15   Up   6.15 (0.45%)   State Bank of India     258.45   Up   3.00 (1.17%)   Sun Pharmaceuticals Industries Ltd     396.80   Up   2.15 (0.54%)   Tata Consultancy Services Ltd     2,037.30   Up   16.30 (0.81%)   Tata Motors Ltd     126.95   Down   -0.90 (-0.70%)   Tata Steel Ltd     349.20   Up   4.35 (1.26%)   Tech Mahindra Ltd     720.50   Down   -0.25 (-0.03%)   Titan Company Ltd     1,272.10   Up   23.15 (1.85%)   UltraTech Cement Ltd     4,206.50   Up   36.20 (0.87%)   UPL Ltd     583.10   Down   -3.55 (-0.61%)   Vedanta Ltd     153.50   Up   5.70 (3.86%)   Wipro Ltd     243.65   Up   0.20 (0.08%)   Yes Bank Ltd     40.60   Up   0.50 (1.25%)   Zee Entertainment Enterprises Ltd     250.70   Up   7.80 (3.21%)      NSE Data  -  www.nseindia.com (5 minutes delayed) syndicated by www.cmots.com

Want Us to Call You?